Syndexa and Technology Transfer at Harvard University Harvard Case Solution & Analysis

Gokhan Hotamisligil is a star researcher at the Harvard School of Public Health, who made pioneering discoveries relationship of fat cells, inflammation and diabetes. Now he wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, Head of Harvard University Technology Development (OTD) seeks to improve the record of Harvard University in the commercialization of science. Describes negotiations between Hotamisligil, OTD, a new company, and the school of public health to establish appropriate licensing and sponsorship agreements research. "Hide
by Richard G. Hamermesh, David Kiron Source: Harvard Business School 19 pages. Publication Date: September 10, 2007. Prod. #: 808073-PDF-ENG

Related Case Solutions & Analyses:

Intel NBI: Image Components Organization MBIntegrative Exercise: Competition & Strategy April 1998 Video PC-Based Desktop Videoconferencing Systems Industry in 1998 Dixon Corp.: The Collinsville Plant Blessed are the Peacemakers: Senator Danforth as Special Envoy to the Sudan Holt Lunsford Commercial Saxon Financial APOLLO TYRES LTD Cycle for Survival Dimensional Fund Advisors